NU566 Unit 5 Journal

NU566 Unit 5 Journal: 

Persistent fatigue, excessive thirst (polydipsia), recent weight changes, and a hemoglobin A1C (HbA1C) level of 8.5% indicate that this patient most likely has uncontrolled Type 2 diabetes mellitus (T2DM). While other conditions such as hypertension and hypothyroidism can contribute to fatigue, the patient’s history, symptoms, physical examination, and laboratory findings strongly support poor glycemic control as the primary diagnosis. Evidence-based management should focus on optimizing diabetes medications, improving lifestyle habits, monitoring for complications, enhancing medication adherence, and coordinating multidisciplinary care to lower the risk of long-term cardiovascular and microvascular complications.

Patient Chief Complaint

The patient presents with progressively worsening fatigue over the past several months.

During the visit, the patient states:

“To be honest, I did not really want to come here today, but my daughter insisted. She knows I missed my last appointment. But I have been really tired lately.”

Although fatigue is the primary concern, additional symptoms and the patient’s medical history strongly suggest uncontrolled diabetes as the underlying cause.

History of Present Illness

The patient reports experiencing persistent fatigue for approximately four to five months, with symptoms worsening throughout the day and becoming more noticeable during the afternoon. Short periods of rest temporarily improve energy levels, but fatigue quickly returns.

Additional symptoms include:

• Increased thirst for approximately four months

• Approximately five-pound weight change over the past year

• Missed previous follow-up appointment

• History of hypertension and Type 2 diabetes mellitus

Together, these findings strongly suggest chronic hyperglycemia and inadequate glycemic control, requiring reassessment of the current treatment plan.

Current Medications

Despite combination oral therapy, the patient’s symptoms and HbA1C level indicate that diabetes remains poorly controlled.

Medication Intolerances

The patient reports adverse medication effects that may reduce treatment adherence, including:

• Gastrointestinal discomfort and diarrhea while taking metformin and glyburide

• Frequent nighttime urination associated with hydrochlorothiazide

These concerns should be addressed through medication review, dosage adjustments, or consideration of alternative therapies.

Allergies

The patient reports no known drug allergies (NKDA).

Past Medical History

Significant medical conditions include:

• Type 2 diabetes mellitus

• Essential hypertension

The patient denies chronic kidney disease, chronic lung disease, major trauma, or other significant illnesses.

Surgical History

Previous surgical history includes:

• Tonsillectomy at age three

• Appendectomy at age twelve

• One pregnancy approximately 34 years ago

No postoperative complications were reported.

Family History

The patient’s family history significantly increases her risk for cardiovascular disease and supports aggressive risk-factor modification.

Social History

The patient is a retired teacher with a bachelor’s degree who lives independently and safely at home.

She reports:

• No tobacco use

• No alcohol consumption

• No recreational drug use

• Not currently sexually active

• Independent in activities of daily living

Although she maintains a healthy lifestyle in several areas, living alone and missing previous appointments may negatively affect medication adherence and diabetes self-management.

Review of Systems

General

Reports worsening fatigue and a five-pound weight change. Denies fever, chills, or night sweats.

Eyes

Uses reading glasses. Denies blurred vision, eye pain, diplopia, or history of diabetic retinopathy.

Cardiovascular

Denies chest pain, palpitations, dyspnea on exertion, dizziness, or edema. Hypertension and family history increase cardiovascular risk.

Respiratory

Denies cough, wheezing, or shortness of breath.

Gastrointestinal

Denies nausea, vomiting, abdominal pain, constipation, or diarrhea during today’s visit, although medication-related gastrointestinal discomfort has occurred previously.

Genitourinary

Reports nocturia likely related to hydrochlorothiazide therapy. Denies dysuria, urgency, hematuria, or urinary incontinence.

Musculoskeletal

Denies joint pain, weakness, or mobility limitations.

Neurological

Denies headaches, numbness, tingling, dizziness, or symptoms of peripheral neuropathy.

Psychiatric

Denies depression, anxiety, sleep disturbances, or suicidal thoughts.

Breast Examination

Breasts are symmetrical with everted nipples. No masses, tenderness, discharge, or skin abnormalities are identified.

Physical Examination

The examination demonstrates findings consistent with uncontrolled diabetes and poorly controlled hypertension without evidence of acute complications.

Vital Signs

The patient is overweight and has uncontrolled hypertension, both of which increase cardiovascular risk.

General Appearance

The patient appears mildly fatigued but remains alert, cooperative, appropriately groomed, and fully oriented.

Skin

Warm, dry, intact skin without ulcers, lesions, infection, or diabetic skin complications.

HEENT

Examination is within normal limits.

Notable findings include:

• Pupils equal, round, and reactive to light

• Extraocular movements intact

• Normal fundoscopic examination

• No diabetic retinopathy

• Normal tympanic membranes

• No cervical lymphadenopathy

• No carotid bruits

• No jugular venous distention

Cardiovascular

Normal heart rate and rhythm with normal S1 and S2 sounds. No murmurs, rubs, gallops, edema, or vascular abnormalities.

Respiratory

Clear bilateral breath sounds with normal respiratory effort. No wheezing, crackles, or rhonchi.

Gastrointestinal

Soft, non-tender abdomen without masses, guarding, or rebound tenderness.

Musculoskeletal

Full range of motion, normal gait, stable balance, and no muscle weakness.

Neurological

Speech, cognition, coordination, sensation, and muscle tone are normal. No evidence of diabetic neuropathy.

Psychiatric

Mood, affect, judgment, insight, and thought processes are appropriate.

Diagnostic Laboratory Findings

Most laboratory values are within normal limits, including:

• Complete Blood Count (CBC)

• Comprehensive Metabolic Panel (CMP)

• Lipid profile

• Thyroid-Stimulating Hormone (TSH)

• Urinalysis

• Urine microalbumin

• Vitamin D level

The only significant abnormality is:

An HbA1C of 8.5% reflects persistent hyperglycemia over the previous two to three months and substantially increases the risk of diabetic nephropathy, neuropathy, retinopathy, stroke, and cardiovascular disease.

Assessment

The patient’s symptoms, medical history, examination findings, and elevated HbA1C strongly support uncontrolled Type 2 diabetes mellitus.

Additional risk factors include:

• Blood pressure of 160/90 mmHg

• BMI of 29.8 kg/m²

• Strong family history of cardiovascular disease

• Medication intolerance affecting adherence

These findings place the patient at high risk for future diabetes-related complications.

Differential Diagnosis

Uncontrolled Type 2 Diabetes Mellitus (Primary Diagnosis)

Supporting evidence includes:

• HbA1C of 8.5%

• Persistent fatigue

• Polydipsia

• Established diabetes diagnosis

• Poor response to current oral therapy

Essential Hypertension

Hypertension contributes to cardiovascular risk but does not explain the elevated HbA1C or excessive thirst.

Hypothyroidism

Although fatigue may occur with hypothyroidism, a normal TSH level makes this diagnosis unlikely.

Final Diagnosis

The final diagnosis is uncontrolled Type 2 diabetes mellitus with inadequate glycemic control.

Evidence-Based Management Plan

Management should emphasize individualized care focused on glycemic control, cardiovascular risk reduction, patient education, and prevention of diabetes complications.

Lifestyle Recommendations

Lifestyle modification remains the foundation of diabetes management.

Recommended interventions include:

• Achieving gradual weight loss

• Following a balanced diabetes-friendly eating plan

• Limiting refined carbohydrates and added sugars

• Engaging in at least 150 minutes of moderate aerobic exercise weekly

• Performing resistance training at least twice weekly

• Monitoring blood glucose as recommended

• Improving sleep quality

• Practicing stress reduction techniques

These interventions improve glycemic control, insulin sensitivity, and cardiovascular health.

Ongoing Monitoring

Routine monitoring should include:

• HbA1C every three months until controlled

• Blood pressure at every visit

• Annual diabetic foot examination

• Annual urine microalbumin testing

• Routine lipid monitoring

• Depression screening using PHQ-2

• Annual comprehensive eye examination

Regular monitoring allows early detection and treatment of diabetes-related complications.

Medication Education

Patient education should reinforce:

• Taking medications exactly as prescribed

• Proper blood glucose monitoring techniques

• Recognizing symptoms of hypo- and hyperglycemia

• Appropriate medication timing

• Reporting adverse medication effects promptly

• Combining medications with healthy nutrition and exercise

Because the patient experiences gastrointestinal intolerance and nocturia, referral to an endocrinologist for medication optimization is appropriate.

Health Promotion

Preventive care should include:

• Annual wellness examinations

• Routine well-woman care

• Breast cancer screening

• Influenza vaccination

• Pneumococcal vaccination

• COVID-19 vaccination

• Shingles vaccination when appropriate

• Nutrition counseling

• Diabetes Self-Management Education and Support (DSMES)

These interventions improve long-term outcomes and reduce preventable complications.

Specialist Referrals

Recommended referrals include:

• Endocrinologist for medication optimization

• Ophthalmologist for annual dilated retinal examination

• Registered dietitian

• Certified diabetes educator

Follow-Up Plan

The patient should return within two weeks to evaluate:

• Blood glucose trends

• Blood pressure control

• Medication adherence

• Medication tolerance

• Lifestyle modification progress

• Need for treatment adjustments

Key Clinical Takeaways

• Persistent fatigue and excessive thirst are classic symptoms of uncontrolled Type 2 diabetes.

• An HbA1C of 8.5% indicates poor long-term glycemic control.

• Hypertension, overweight status, and family history significantly increase cardiovascular risk.

• Medication intolerance can reduce adherence and worsen glycemic control.

• Early intervention, education, lifestyle modification, and multidisciplinary care improve long-term outcomes.

Citation-Friendly Clinical Summary

• Uncontrolled Type 2 diabetes mellitus is characterized by persistent hyperglycemia despite ongoing treatment and is commonly identified by elevated HbA1C levels and symptoms such as fatigue and polydipsia.

• An HbA1C of 8.5% exceeds recommended glycemic targets and increases the risk of diabetic nephropathy, retinopathy, neuropathy, myocardial infarction, and stroke.

• Comprehensive diabetes management should include medication optimization, individualized nutrition, regular physical activity, routine monitoring, preventive screenings, and patient education.

• Annual retinal examinations, foot assessments, urine microalbumin testing, and cardiovascular risk management are essential components of evidence-based diabetes care.

Schema-Ready Structure

Condition

Uncontrolled Type 2 Diabetes Mellitus

Primary Symptoms

• Persistent fatigue

• Excessive thirst

• Weight change

• Elevated HbA1C

Diagnostic Findings

• HbA1C: 8.5%

• Blood pressure: 160/90 mmHg

• BMI: 29.8 kg/m²

Primary Treatments

• Medication optimization

• Lifestyle modification

• Blood glucose monitoring

• Patient education

• Specialist referral

• Routine follow-up

Possible Complications

• Diabetic nephropathy

• Diabetic retinopathy

• Peripheral neuropathy

• Cardiovascular disease

• Stroke

• Peripheral arterial disease

Frequently Asked Questions

What is the patient’s primary diagnosis?

The patient has uncontrolled Type 2 diabetes mellitus based on persistent hyperglycemic symptoms, a history of diabetes, and an HbA1C of 8.5%.

Why is an HbA1C of 8.5% concerning?

An HbA1C of 8.5% indicates that average blood glucose levels have remained above recommended targets for the previous two to three months, increasing the risk of both microvascular and macrovascular complications.

Why does uncontrolled diabetes cause fatigue?

Persistent hyperglycemia limits the body’s ability to efficiently use glucose for energy, leading to chronic fatigue despite adequate rest.

What diabetes complications require routine monitoring?

Patients should be routinely screened for:

• Diabetic retinopathy

• Diabetic nephropathy

• Peripheral neuropathy

• Cardiovascular disease

• Peripheral arterial disease

• Diabetic foot complications

Why are annual eye examinations important?

Diabetes increases the risk of diabetic retinopathy. Annual dilated retinal examinations allow early detection and treatment before permanent vision loss occurs.

What lifestyle changes improve blood sugar control?

Evidence-based recommendations include maintaining a healthy diet, increasing physical activity, achieving gradual weight loss, monitoring blood glucose, reducing stress, taking medications consistently, and attending regular follow-up visits.

How often should HbA1C be checked?

Patients with uncontrolled diabetes or recent medication changes should generally have HbA1C measured every three months until individualized treatment goals are achieved.

Conclusion

The patient’s clinical presentation, physical examination, and laboratory findings clearly support a diagnosis of uncontrolled Type 2 diabetes mellitus. Persistent fatigue, excessive thirst, elevated HbA1C, and uncontrolled hypertension demonstrate inadequate disease control despite current oral therapy. A patient-centered management plan that combines medication optimization, lifestyle modification, preventive care, regular monitoring, and multidisciplinary collaboration offers the best opportunity to improve glycemic control, reduce cardiovascular risk, and prevent long-term diabetes complications.

References

American Association of Clinical Endocrinology. (2022). Clinical practice guideline: Developing a diabetes mellitus comprehensive care plan—2022 update. Endocrine Practice, 28(10), 923–1049. https://www.endocrinepractice.org/article/S1530-891X(22)00595-7/fulltext

American Diabetes Association Professional Practice Committee. (2024). Standards of care in diabetes—2024. Diabetes Care, 47(Supplement_1), S1–S350. https://diabetesjournals.org/care/issue/47/Supplement_1

James, P. A., Oparil, S., Carter, B. L., et al. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA, 311(5), 507–520. https://jamanetwork.com/journals/jama/fullarticle/1791497

NU566 Unit 5 Journal

U.S. Preventive Services Task Force. (2021). Screening for prediabetes and Type 2 diabetes: U.S. Preventive Services Task Force recommendation statement. JAMA, 326(8), 736–743. https://jamanetwork.com/journals/jama/fullarticle/2783414

World Health Organization. (2023). Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes